Exosome Based Cancer Therapy: The Future of Targeted Treatment / cancer, Exosome based cancer therapy, OncoDaily, Oncology

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for developing extra-hepatic cancers. Now, Li et al. uncover an exosome-driven metabolic connection between the steatotic liver and the breast that fosters cancer progression.

Patrick Gelsinger, executive chairman of Gloo, has made it his mission to advance Christian principles in Silicon Valley

In this study, we downloaded 5 datasets from the GEO database, including GSE18842, GSE19188, GSE19804, GSE75037, and GSE103512. In addition, we also downloaded LUAD and LUSC datasets from the TCGA database for validation, comprising 110 normal tissue samples and 1043...

Discover Ampleur's new anti-aging skincare series featuring advanced ingredients like exosomes, aimed at addressing multiple skin concerns effectively.

A recent publication in Nature Communications highlights PranaX's licensed exosome technology, marking a significant step in regenerative medicine advancements.

In the world of skincare, trends come and go faster than you can double-tap a TikTok tutorial. From slugging to exosome serums,… The post From Viral Hacks To Proven Treatments: The Skincare Trends That Actually Work For Black Women, According To A Pro appeared first on Shine My Crown.

Abstract Alzheimer's disease (AD) is a common form of dementia characterized by memory loss, cognitive and linguistic abilities declining and self-care capabilities diminishment. With the aging population globally, AD poses a significant threat to public health. Current treatments for AD aim to alleviate symptoms and slow down disease progression, but due to the limited understanding of underlying disease mechanisms, AD is still impossible to be cured yet. In recent years, there has been an exponential growth in exosome-related research because of their excellent biocompatibility ability, loading capacity and cellular internalization, making exosome to be one of the hotspots and a promising strategy in AD therapy research. This comprehensive review systematically explores the potential roles of various exosome-based nanotherapeutic strategy in AD treatment, with a particular focus on their specific biological mechanisms of action. Firstly, we elaborated on the pathological mechanisms of AD formation as well as the mechanisms related to the formation, secretion and function of exosome. Additionally, we highlighted the research progress in the development of exosome-based nanotherapeutic strategies for AD treatment and their corresponding biological mechanisms. Furthermore, we delved into the challenges and opportunities these strategies facing in clinical application. Looking forward to future research directions and trends, our review aims to provide a more comprehensive understanding and guidance with the application of exosome in AD treatment. Exosome-based nanotherapeutic strategies, as a new therapeutic approach, have opened up new possibilities for the treatment of AD and brought new light to patients. Graphical abstract Schematic diagram of exosome-based nanotherapy strategies for the treatment of AD. It can be roughly classified as: exosomes-based methods treating AD and bioengineered exosomes for the treatment of AD.

Emerging research reveals a groundbreaking link between genetic regulation of exosome biogenesis and metabolic disorders such as obesity and insulin resistance, with significant implications for our understanding of cellular communication in human tissues. Exosomes, the nanosized vesicles released by cells, have long

Emerging research reveals a groundbreaking link between genetic regulation of exosome biogenesis and metabolic disorders such as obesity and insulin

Emerging research reveals a groundbreaking link between genetic regulation of exosome biogenesis and metabolic disorders such as obesity and insulin

Emerging research reveals a groundbreaking link between genetic regulation of exosome biogenesis and metabolic disorders such as obesity and insulin

Emerging research reveals a groundbreaking link between genetic regulation of exosome biogenesis and metabolic disorders such as obesity and insulin

Pancreatic cancer (PaC) remains one of the deadliest cancers, with 5-year survival rates of 13%. A major driver of its aggressiveness is the tumour microenvironment (TME), which fuels tumour growth, m...

Author(s): Scott Douglas Jacobsen Publication (Outlet/Website): The Good Men Project Publication Date (yyyy/mm/dd): 2025/07/10 Dr. Joshua Korman, a Stanford-trained, board-certified plastic surgeon and founder of Korman Plastic Surgery, discusses his background in music, sculpting, fitness, and plastic surgery innovations. He explains the role of exosomes and gene therapy in accelerating healing, ethical considerations in younger patients seeking surgery, and the blurred lines between vanity and necessity.